| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 5 | -474K | 100% | $77.78 | -$36.9M |
| Net | -5 | -474K | -100% | -$36.9M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Christopher D. Alafi | Director | $377M | May 27, 2021 | ||
| Richard A. Lerner | Director | $7.16M | Sep 30, 2021 | ||
| Lawrence J. Hineline | SVP of Finance, CFO | $372K | Mar 7, 2024 | ||
| Suresh K. Durgam | EVP, Chief Medical Officer | $0 | Apr 2, 2025 | ||
| Rory B. Riggs | Director | $0 | -$337K | -100% | Apr 2, 2025 |
| Joel S. Marcus | Director | $0 | Apr 2, 2025 | ||
| Mark Neumann | EVP, Chief Commercial Officer | $0 | -$1.41M | -100% | Apr 2, 2025 |
| Sharon Mates | Chairman and CEO, Director | $0 | -$30M | -100% | Apr 2, 2025 |
| Eduardo Rene Salas | Director | $0 | Apr 2, 2025 | ||
| Robert L. Van Nostrand | Director | $0 | -$1.52M | -100% | Apr 2, 2025 |
| Sanjeev Narula | Executive Vice President & CFO | $0 | Apr 2, 2025 | ||
| Michael Halstead | President | $0 | -$3.69M | -100% | Apr 2, 2025 |
| Michael Rawlins | Director | Jun 9, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|